Emerging role of antibiotics in atherosclerosis

E P Gurfinkel1, G Bozovich

  • 1Coronary Care Unit, Fundación Favaloro, Argentina. gurfi001@ffinme.edu.ar

American Heart Journal
|October 28, 1999
PubMed

Insights

Inflammation and pathogens like Chlamydia pneumoniae may drive acute coronary syndromes. The WIZARD trial investigates if antibiotics improve outcomes for coronary heart disease patients.

Area of Science:

  • Cardiovascular Medicine
  • Infectious Disease Immunology

Background:

  • Plaque composition shifts during acute cardiovascular events, with macrophages and T cells dominating.
  • Blood flow dynamics, plaque structure, and inflammatory cell distribution are interconnected.
  • Intracellular pathogens, including Chlamydia pneumoniae and cytomegalovirus, are implicated in arterial wall inflammation.

Purpose of the Study:

  • To explore the role of intracellular pathogens in acute coronary syndromes.
  • To evaluate the efficacy of antibiotic treatment in coronary heart disease patients.

Main Methods:

  • Analysis of plaque composition in acute cardiovascular events.
  • Review of evidence for intracellular pathogens in atherosclerosis.
  • Evaluation of clinical trial data (ROXIS and WIZARD trials).

Main Results:

  • Macrophages and T cells are key inflammatory cells at sites of plaque rupture.
  • Evidence suggests intracellular pathogens affect vascular cells and macrophages.
  • The ROXIS trial indicated a potential role for pathogens in acute coronary syndromes.

Conclusions:

  • Intracellular pathogens may contribute to acute coronary syndromes.
  • The WIZARD trial is assessing the benefit of antibiotics for improved outcomes in coronary patients.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...